DYAI
DYADIC INTERNATIONAL INC
Company overview
- Market capitalization
- $16.94M
- Employees
- 5
- Latest publication
- 2026-09-29
About DYADIC INTERNATIONAL INC
Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector; and C1 Protein Production Platform, a thermophilic fungal platform for large-scale production of proteins. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd; license agreement with Rubic One Health to develop various livestock vaccines; and sub-license agreement with Phibro Animal Health/Abic Biological Laboratories to develop vaccines and treatments for livestock diseases. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 961,138USD | 1,110,956USD | 235,716USD | 1,164,617USD | 463,449USD | 183,100USD | 817,376USD | 1,957,500USD |
| Cost Of Revenue | 984,165USD | 791,840USD | 384,608USD | 254,753USD | 613,591USD | 297,658USD | 352,819USD | 395,894USD |
| Gross Profit | -23,027USD | 319,116USD | -148,892USD | 909,864USD | -150,142USD | -114,558USD | 464,557USD | 1,561,606USD |
| Research Development | 332,621USD | 476,069USD | 458,436USD | 350,046USD | 629,379USD | 494,979USD | 545,660USD | 460,241USD |
| Selling General Administrative | 1,689,863USD | 1,755,331USD | 1,247,411USD | 1,481,356USD | 1,436,630USD | 1,596,338USD | 1,440,439USD | 1,297,984USD |
| General And Administrative Expenses | 1,689,863USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 2,031,177USD | 2,231,400USD | 1,376,037USD | 2,835,233USD | 1,578,926USD | 1,887,917USD | 1,994,616USD | 1,764,220USD |
| Operating Income | -2,054,204USD | -1,912,284USD | -1,524,929USD | -1,925,369USD | -1,729,068USD | -2,002,475USD | -1,530,059USD | -202,614USD |
| Total Other Income Expense Net | -69,680USD | -42,399USD | -42,334USD | -50,643USD | -64,706USD | -25,104USD | -20,821USD | -846USD |
| Interest Income | 39,705USD | 57,191USD | 83,033USD | 63,467USD | 49,127USD | 88,458USD | 103,747USD | 127,331USD |
| Net Income | -2,123,884USD | -1,954,683USD | -1,567,263USD | -1,976,012USD | -1,793,774USD | -2,027,579USD | -1,550,880USD | -203,460USD |
| Interest Expense | — | 109,181USD | 114,392USD | 85,934USD | 113,833USD | 113,562USD | 126,233USD | 128,177USD |
| Net Interest Income | — | -51,990USD | -31,359USD | -50,643USD | -64,706USD | -25,104USD | -22,486USD | -846USD |
| Income Before Tax | — | -1,954,683USD | -1,567,263USD | -1,976,012USD | -1,793,774USD | -2,027,579USD | -1,550,880USD | -203,460USD |
| Net Income From Continuing Ops | — | -1,954,683USD | -1,567,263USD | -1,976,012USD | -1,793,774USD | -2,027,579USD | -1,550,880USD | -203,460USD |
| Ebitda | — | -1,912,284USD | -1,452,871USD | -1,890,078USD | -1,679,941USD | -1,914,017USD | -1,424,645USD | -75,288USD |
| Unclassified Operating Expenses | — | — | — | 1,003,831USD | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | 43,277USD | — |
| Ebit | — | — | — | — | — | — | -2,097,483USD | -202,614USD |
| Depreciation And Amortization | — | — | — | — | — | — | -2,247,981USD | 127,326USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,232,311USD | 3,495,389USD | 2,898,806USD | 2,930,303USD | 2,403,831USD | 1,601,921USD | 1,681,076USD | 1,295,451USD |
| Cost Of Revenue | 2,319,860USD | 1,194,624USD | 1,975,849USD | 2,123,193USD | 1,944,438USD | 1,424,931USD | 1,459,701USD | 1,027,278USD |
| Gross Profit | -1,087,549USD | 2,300,765USD | 922,957USD | 807,110USD | 459,393USD | 176,990USD | 221,375USD | 268,173USD |
| Research Development | 2,154,666USD | 2,044,253USD | 3,297,266USD | 4,501,365USD | 8,392,370USD | 3,868,121USD | 5,416,018USD | 3,317,164USD |
| Selling General Administrative | 5,761,735USD | 6,134,773USD | 5,817,013USD | 6,421,505USD | 6,697,617USD | 6,084,799USD | 5,519,922USD | 4,522,676USD |
| Unclassified Operating Expenses | -1,858,034USD | — | — | — | — | — | -1,431,976USD | — |
| Total Operating Expenses | 6,058,367USD | 8,201,587USD | 9,152,696USD | 10,972,788USD | 15,186,880USD | 10,202,653USD | 9,503,964USD | 7,839,840USD |
| Operating Income | -7,145,916USD | -5,900,822USD | -8,229,739USD | -10,165,678USD | -14,727,487USD | -10,025,663USD | -9,282,589USD | -7,592,445USD |
| Interest Income | 284,085USD | 456,992USD | 416,686USD | 180,420USD | 51,704USD | 446,999USD | 984,930USD | 894,530USD |
| Interest Expense | 455,897USD | 427,971USD | 0USD | 380,502USD | 51,704USD | 731,708USD | 984,930USD | 894,532USD |
| Net Interest Income | -171,812USD | 29,021USD | 416,686USD | 180,420USD | 51,704USD | 446,999USD | 984,930USD | 894,532USD |
| Income Before Tax | -7,364,628USD | -5,809,159USD | -6,795,461USD | -9,735,258USD | -13,070,251USD | -9,293,955USD | -8,297,658USD | -6,697,913USD |
| Net Income | -7,364,628USD | -5,809,159USD | -6,795,461USD | -9,735,258USD | -13,070,251USD | -9,325,273USD | -8,307,964USD | -5,691,756USD |
| Net Income From Continuing Ops | -7,364,628USD | -5,809,159USD | -6,795,461USD | -9,735,258USD | -13,070,251USD | -9,325,273USD | -8,307,965USD | -5,691,756USD |
| Ebitda | -6,908,731USD | -5,381,188USD | -8,152,905USD | -10,115,760USD | -11,140,450USD | -9,963,318USD | -9,227,139USD | -7,550,889USD |
| Total Other Income Expense Net | -218,712USD | 91,663USD | 1,434,278USD | 430,420USD | 1,657,236USD | 731,708USD | 984,931USD | 894,532USD |
| Income Tax Expense | — | -5,809,159USD | -8,191,322USD | -364,374USD | -148,597USD | 31,318USD | 10,306USD | -1,006,157USD |
| Ebit | — | -11,259,450USD | -8,191,322USD | -20,181,602USD | -14,630,594USD | -20,149,000USD | -18,482,003USD | -14,954,556USD |
| Depreciation And Amortization | — | 5,878,261USD | 38,417USD | 10,115,760USD | 3,490,144USD | 9,963,318USD | 9,254,864USD | 7,403,667USD |
| Net Income Applicable To Common Shares | — | — | — | -9,735,258USD | -13,070,251USD | -9,325,273USD | -8,307,965USD | -5,691,756USD |
| Tax Provision | — | — | — | — | 0USD | 31,318USD | 10,306USD | -1,006,157USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 6,536,531USD | 7,809,573USD | 9,945,725USD | 11,672,757USD | 8,138,045USD | 7,894,878USD | 9,930,275USD | 10,805,666USD |
| Cash And Equivalents | 1,425,364USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 3,113,719USD | 6,516,771USD | 7,320,992USD | 10,254,628USD | 4,983,318USD | 7,349,413USD | 9,263,327USD | 9,922,446USD |
| Short Term Investments | 1,688,355USD | 1,361,043USD | 2,698,661USD | 3,098,840USD | 2,842,419USD | 2,284,472USD | 2,756,577USD | 4,000,832USD |
| Total Current Assets | 6,406,764USD | 7,699,896USD | 9,896,653USD | 11,545,262USD | 7,406,739USD | 7,805,212USD | 9,827,668USD | 10,690,424USD |
| Other Current Assets | 418,943USD | 174,238USD | 1,450,235USD | 339,943USD | 1,708,104USD | 234,080USD | 327,314USD | 374,209USD |
| Other Non Current Assets | 10,500USD | — | — | — | — | — | — | — |
| Total Liabilities | 8,923,775USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 3,882,765USD | 3,183,880USD | 3,687,271USD | 4,051,972USD | 3,661,552USD | 1,962,160USD | 2,448,017USD | 2,077,176USD |
| Other Current Liabilities | 1,395,680USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | -2,387,244USD | -407,732USD | 1,232,410USD | 2,607,334USD | -529,701USD | 923,611USD | 2,470,290USD | 3,412,112USD |
| Total Equity Including Noncontrolling Interest | -2,387,244USD | — | — | — | — | — | — | — |
| Deferred Revenue | 1,564,172USD | — | — | — | — | — | — | — |
| Net Receivables | 1,302,439USD | 1,008,887USD | 1,125,426USD | 950,691USD | 715,317USD | 221,719USD | 237,027USD | 393,769USD |
| Property Plant Equipment Net | 9,851USD | 24,354USD | 38,535USD | 52,401USD | 65,961USD | 79,229USD | 92,211USD | 104,914USD |
| Accounts Payable | 816,059USD | 1,060,092USD | 852,024USD | 705,834USD | 738,794USD | 448,390USD | 482,320USD | 561,797USD |
| Short Term Debt | 5,054USD | 19,998USD | 34,621USD | 48,927USD | 57,577USD | 55,895USD | 54,249USD | 53,476USD |
| Common Stock | 48,693USD | 48,693USD | 48,442USD | 48,442USD | 42,390USD | 42,368USD | 42,090USD | 41,843USD |
| Retained Earnings | -97,529,675USD | -95,405,791USD | -93,451,108USD | -91,883,845USD | -89,907,833USD | -88,114,059USD | -86,086,480USD | -84,535,600USD |
| Total Liab | — | 8,217,305USD | 8,713,315USD | 9,065,423USD | 8,667,746USD | 6,971,267USD | 7,459,985USD | 7,393,554USD |
| Other Current Liab | — | 993,220USD | 2,800,626USD | 1,960,073USD | 2,865,181USD | 1,457,875USD | 1,911,448USD | 947,420USD |
| Capital Stock | — | 48,693USD | 48,442USD | 48,442USD | 42,390USD | 42,368USD | 42,090USD | 41,843USD |
| Cash | — | 5,155,728USD | 4,622,331USD | 7,155,788USD | 2,140,899USD | 5,064,941USD | 6,506,750USD | 5,921,614USD |
| Current Deferred Revenue | — | 1,110,570USD | — | 1,337,138USD | 1,833,531USD | — | — | 514,483USD |
| Net Debt | — | -102,305USD | 438,334USD | -2,093,410USD | 2,922,873USD | 61USD | -1,440,533USD | -551,760USD |
| Short Long Term Debt Total | — | 5,053,423USD | 5,060,665USD | 5,062,378USD | 5,063,772USD | 5,065,002USD | 5,066,217USD | 5,369,854USD |
| Long Term Debt | — | 5,033,425USD | 5,026,044USD | 5,013,451USD | 5,001,141USD | 4,989,109USD | 4,977,347USD | 5,268,287USD |
| Long Term Investments | — | 74,812USD | — | 64,561USD | 409,670USD | — | — | — |
| Property Plant Equipment Gross | — | 24,354USD | 38,535USD | 52,401USD | 65,961USD | 79,229USD | 92,211USD | 104,914USD |
| Common Stock Shares Outstanding | — | 36,397,997shares | 32,624,323shares | 34,507,530shares | 30,102,324shares | 29,886,665shares | 29,318,123shares | 29,503,143shares |
| Non Current Assets Total | — | 109,677USD | 49,072USD | 127,495USD | 731,306USD | 89,666USD | 102,607USD | 115,242USD |
| Non Current Liabilities Total | — | 5,033,424USD | 5,026,044USD | 5,013,450USD | 5,006,194USD | 5,009,107USD | 5,011,968USD | 5,316,378USD |
| Non Currrent Assets Other | — | 10,511USD | 10,537USD | 10,533USD | 255,675USD | 10,437USD | 10,396USD | 10,328USD |
| Net Working Capital | — | 4,516,016USD | 6,209,382USD | 7,493,290USD | 3,745,187USD | 5,843,052USD | 7,379,651USD | 8,613,248USD |
| Unclassified Equity | — | 94,900,673USD | 94,586,634USD | 94,394,295USD | 89,293,352USD | 88,952,934USD | 88,472,590USD | 87,864,026USD |
| Accumulated Other Comprehensive Income | — | — | — | — | 0USD | 0USD | 0USD | — |
| Unclassified Current Liabilities | — | — | — | — | -1,833,531USD | — | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 9,945,725USD | 9,930,275USD | 8,219,236USD | 13,712,818USD | 21,299,122USD | 30,072,432USD | 37,452,496USD | 43,300,807USD |
| Other Current Assets | 1,450,235USD | 327,314USD | 337,858USD | 450,521USD | 375,830USD | 280,555USD | 277,999USD | 425,447USD |
| Total Liab | 8,713,315USD | 7,459,985USD | 2,340,651USD | 2,625,079USD | 2,908,660USD | 1,625,871USD | 1,588,025USD | 849,638USD |
| Total Stockholder Equity | 1,232,410USD | 2,470,290USD | 5,878,585USD | 11,087,739USD | 18,390,462USD | 28,446,561USD | 35,864,471USD | 42,451,169USD |
| Other Current Liab | 2,800,626USD | 1,911,448USD | 1,547,277USD | 1,172,295USD | 860,707USD | 612,772USD | 644,647USD | 540,578USD |
| Common Stock | 48,442USD | 42,090USD | 41,065USD | 40,817USD | 40,483USD | 39,748USD | 39,613USD | 38,967USD |
| Capital Stock | 48,442USD | 42,090USD | 41,065USD | 40,817USD | 40,483USD | 39,748USD | 39,613USD | 38,967USD |
| Retained Earnings | -93,451,108USD | -86,086,480USD | -80,277,321USD | -73,481,860USD | -63,746,602USD | -50,676,351USD | -41,351,078USD | -33,043,113USD |
| Cash | 4,622,331USD | 6,506,750USD | 6,515,028USD | 5,794,272USD | 15,748,480USD | 20,637,045USD | 4,823,544USD | 2,386,314USD |
| Cash And Short Term Investments | 7,320,992USD | 9,263,327USD | 7,263,318USD | 12,641,542USD | 20,260,260USD | 29,094,497USD | 34,222,690USD | 41,202,755USD |
| Total Current Assets | 9,896,653USD | 9,827,668USD | 8,067,335USD | 13,422,064USD | 21,008,296USD | 29,781,498USD | 35,639,238USD | 42,748,052USD |
| Total Current Liabilities | 3,687,271USD | 2,448,017USD | 2,251,781USD | 2,448,608USD | 2,555,719USD | 1,625,871USD | 1,588,025USD | 849,638USD |
| Net Debt | 438,334USD | -1,440,533USD | -6,378,099USD | -5,794,272USD | -15,748,480USD | -20,637,045USD | -4,823,544USD | -2,386,314USD |
| Short Term Debt | 34,621USD | 54,249USD | 48,059USD | — | — | 123,016USD | 78,644USD | — |
| Short Long Term Debt Total | 5,060,665USD | 5,066,217USD | 136,929USD | — | — | — | — | — |
| Long Term Debt | 5,026,044USD | 4,977,347USD | — | — | — | — | — | — |
| Short Term Investments | 2,698,661USD | 2,756,577USD | 748,290USD | 6,847,270USD | 4,511,780USD | 8,457,452USD | 29,399,146USD | 38,816,441USD |
| Net Receivables | 1,125,426USD | 237,027USD | 466,159USD | 330,001USD | 372,206USD | 406,446USD | 1,138,549USD | 1,119,850USD |
| Accounts Payable | 852,024USD | 482,320USD | 656,445USD | 1,276,313USD | 1,547,953USD | 1,013,099USD | 943,378USD | 309,060USD |
| Property Plant Equipment Net | 38,535USD | 92,211USD | 141,439USD | 0USD | — | — | — | — |
| Property Plant Equipment Gross | 38,535USD | 92,211USD | 141,439USD | 0USD | — | — | — | — |
| Common Stock Shares Outstanding | 32,624,323shares | 29,318,123shares | 28,798,833shares | 28,364,482shares | 27,838,047shares | 27,471,587shares | 27,003,695shares | 27,673,300shares |
| Non Current Assets Total | 49,072USD | 102,607USD | 151,901USD | 290,754USD | 290,826USD | 290,934USD | 1,813,258USD | 552,755USD |
| Non Current Liabilities Total | 5,026,044USD | 5,011,968USD | 88,870USD | 176,471USD | 352,941USD | 1,013,099USD | 943,378USD | 309,060USD |
| Non Currrent Assets Other | 10,537USD | 10,396USD | 10,462USD | 6,045USD | 6,117USD | 6,225USD | 301,622USD | 52,140USD |
| Net Working Capital | 6,209,382USD | 7,379,651USD | 5,815,554USD | 10,973,456USD | 18,452,577USD | 28,155,627USD | 34,051,213USD | 41,898,414USD |
| Unclassified Equity | 94,586,634USD | 88,472,590USD | 86,073,776USD | 84,487,965USD | 82,056,098USD | 79,043,416USD | 96,066,243USD | 94,346,268USD |
| Accumulated Other Comprehensive Income | — | 0USD | 0USD | 0USD | 0USD | 0USD | — | 0USD |
| Current Deferred Revenue | — | — | 490,113USD | 176,471USD | 147,059USD | 123,016USD | 78,644USD | 141,002USD |
| Long Term Investments | — | — | 0USD | 284,709USD | 284,709USD | 284,709USD | 1,511,636USD | 0USD |
| Inventory | — | — | 1USD | — | — | 1USD | — | 253,446USD |
| Other Liab | — | — | — | 176,471USD | 352,941USD | — | — | — |
| Other Assets | — | — | — | 6,045USD | 6,117USD | 290,934USD | 301,622USD | 552,755USD |
| Net Tangible Assets | — | — | — | 11,087,739USD | 18,390,462USD | 28,446,561USD | 35,864,471USD | 42,451,169USD |
| Unclassified Non Current Liabilities | — | — | — | — | — | 1,013,099USD | — | — |
| Treasury Stock | — | — | — | — | — | — | -18,929,920USD | -18,929,920USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -1,954,683USD | -1,567,263USD | -1,976,012USD | -1,793,774USD | -2,027,579USD | -1,550,880USD | -203,460USD | -2,045,223USD |
| Depreciation | -3,390USD | 18,342USD | -26,515USD | -5,997USD | 11,762USD | 4,572USD | -71,801USD | 23,592USD |
| Stock Based Compensation | 139,299USD | 192,339USD | 172,352USD | 340,462USD | 225,030USD | 274,808USD | 247,390USD | 297,603USD |
| Other Non Cash Items | 133,699USD | 1,809USD | 20,310USD | 28,130USD | -2,927USD | 3,985USD | -1,099USD | 2,867USD |
| Change To Account Receivables | 112,081USD | -174,674USD | -200,823USD | -498,661USD | 16,313USD | 121,198USD | -108,586USD | -18,591USD |
| Change In Working Capital | -142,350USD | -415,338USD | -69,014USD | 1,301,164USD | -156,017USD | 571,120USD | -243,888USD | -219,622USD |
| Total Cash From Operating Activities | -1,963,334USD | -1,770,111USD | -1,852,364USD | -130,015USD | -1,949,731USD | -696,395USD | -201,057USD | -1,964,375USD |
| Capital Expenditures | -4USD | 0USD | -4USD | 0USD | 0USD | -5USD | -5USD | -5USD |
| Free Cash Flow | -1,963,330USD | -1,770,111USD | -1,852,360USD | -130,015USD | -1,949,731USD | -696,395USD | -201,057USD | -1,964,380USD |
| Investments | 1,266,196USD | 468,159USD | 93,442USD | -961,620USD | 482,104USD | 1,263,275USD | -11,977USD | -2,472,644USD |
| Total Cashflows From Investing Activities | 1,266,196USD | 468,159USD | 93,442USD | -961,620USD | 482,104USD | 1,263,275USD | -11,977USD | -2,472,644USD |
| Total Cash From Financing Activities | 0USD | -1USD | 4,940,696USD | 0USD | 24,249USD | 24,251USD | 0USD | 0USD |
| Change In Cash | -697,771USD | -1,302,289USD | 3,426,505USD | -1,090,511USD | -1,441,809USD | 585,136USD | -211,784USD | -4,436,416USD |
| Begin Period Cash Flow | 5,853,499USD | 7,155,788USD | 3,729,283USD | 5,064,941USD | 6,506,750USD | 5,921,614USD | 6,133,398USD | 10,569,814USD |
| End Period Cash Flow | 5,155,728USD | 5,853,499USD | 7,155,788USD | 3,974,430USD | 5,064,941USD | 6,506,750USD | 5,921,614USD | 6,133,398USD |
| Net Borrowings | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | — |
| Issuance Of Capital Stock | — | -1USD | — | — | — | — | — | — |
| Other Cashflows From Financing Activities | — | — | 4,940,696USD | — | 24,249USD | 5,824,326USD | -11,977USD | -2,472,644USD |
| Other Cashflows From Investing Activities | — | — | — | — | — | 5USD | -5USD | — |
| Unclassified Financing Cash Flow | — | — | — | — | — | -5,800,075USD | — | 2,472,644USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -7,364,628USD | -5,809,159USD | -6,795,461USD | -9,735,258USD | -13,070,251USD | -9,325,273USD | -8,307,964USD | -5,691,756USD |
| Depreciation | -24,169USD | -71,057USD | -53,032USD | 33,790USD | 329,612USD | 331,277USD | 198,208USD | 676,644USD |
| Stock Based Compensation | 930,183USD | 1,126,279USD | 1,244,121USD | 1,888,944USD | 1,784,102USD | 1,651,893USD | 1,171,079USD | 467,203USD |
| Other Non Cash Items | 95,598USD | -46,452USD | -1,032,206USD | 83,708USD | -1,179,027USD | 108,913USD | 1,397,011USD | 697,422USD |
| Change To Account Receivables | -857,845USD | 205,260USD | -93,130USD | -47,175USD | -13,920USD | 1,081,445USD | 218,623USD | -59,984USD |
| Change In Working Capital | 660,795USD | 754,526USD | -143,209USD | -321,169USD | 1,188,231USD | 990,075USD | 1,128,061USD | 119,942USD |
| Total Cash From Operating Activities | -5,702,221USD | -3,974,806USD | -6,726,755USD | -8,083,775USD | -11,276,945USD | -6,574,392USD | -5,782,892USD | -4,407,189USD |
| Capital Expenditures | 0USD | -4USD | -5USD | -5USD | -5USD | -2USD | -2USD | 0USD |
| Free Cash Flow | -5,702,221USD | -3,974,810USD | -6,726,755USD | -8,083,775USD | -11,276,945USD | -6,574,390USD | -5,782,890USD | -4,407,189USD |
| Investments | 82,085USD | -1,876,253USD | 7,449,896USD | -2,369,280USD | 5,221,592USD | 22,122,053USD | 7,707,450USD | 3,328,319USD |
| Total Cashflows From Investing Activities | 82,085USD | -1,876,253USD | 7,449,896USD | -2,369,280USD | 5,221,592USD | 22,122,053USD | 7,707,450USD | 3,328,319USD |
| Net Borrowings | 0USD | 5,824,326USD | 0USD | — | — | — | — | — |
| Total Cash From Financing Activities | 4,964,944USD | 5,848,577USD | 0USD | 543,591USD | 1,230,050USD | 255,469USD | 550,188USD | -2,299,542USD |
| Issuance Of Capital Stock | 4,940,695USD | 0USD | — | — | — | — | — | — |
| Change In Cash | -653,251USD | -8,278USD | 720,756USD | -9,954,208USD | -4,888,565USD | 15,813,501USD | 2,437,230USD | -3,400,034USD |
| Begin Period Cash Flow | 6,506,750USD | 6,515,028USD | 5,794,272USD | 15,748,480USD | 20,637,045USD | 4,823,544USD | 2,386,314USD | 5,786,348USD |
| End Period Cash Flow | 5,853,499USD | 6,506,750USD | 6,515,028USD | 5,794,272USD | 15,748,480USD | 20,637,045USD | 4,823,544USD | 2,386,314USD |
| Other Cashflows From Financing Activities | 4,964,944USD | 24,251USD | 7,449,896USD | 543,591USD | 1,230,050USD | 255,470USD | 550,188USD | 4,500USD |
| Unclassified Financing Cash Flow | -4,940,695USD | — | -7,449,896USD | — | — | — | — | — |
| Change To Liabilities | — | — | — | -505,590USD | 1,077,693USD | -8,828USD | 824,057USD | -44,813USD |
| Other Cashflows From Investing Activities | — | — | — | -2,369,280USD | 5,221,592USD | 22,122,053USD | 7,707,450USD | 3,328,319USD |
| Unclassified Investing Cash Flow | — | — | — | 2,369,285USD | -5,221,587USD | -22,122,051USD | -7,707,448USD | -3,328,319USD |
| Change To Inventory | — | — | — | — | 142,330USD | 635,538USD | 785,533USD | 234,679USD |
| Sale Purchase Of Stock | — | — | — | — | — | — | 550,188USD | -2,304,042USD |
| Cash And Cash Equivalents Changes | — | — | — | — | — | — | 2,474,746USD | -3,378,412USD |
| Unclassified Operating Cash Flow | — | — | — | — | — | — | -1,369,287USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Product | Grant | 487,366 | USD | 0001493152-26-022722 |
| Q1 2026Quarterly · 2026-03-31 | Product | License | 220,000 | USD | 0001493152-26-022722 |
| Q1 2026Quarterly · 2026-03-31 | Product | Research And Development Expenses | 403,590 | USD | 0001493152-26-022722 |
| FY 2025Yearly · 2025-12-31 | Product | Grant | 1,858,034 | USD | 0001493152-26-012672 |
| FY 2025Yearly · 2025-12-31 | Product | License | 265,000 | USD | 0001493152-26-012672 |
| FY 2025Yearly · 2025-12-31 | Product | Research And Development | 967,311 | USD | 0001493152-26-012672 |
| Q3 2025Quarterly · 2025-09-30 | Product | Grant | 814,571 | USD | 0001493152-25-021908 |
| Q3 2025Quarterly · 2025-09-30 | Product | Research And Development | 350,046 | USD | 0001493152-25-021908 |
| Q2 2025Quarterly · 2025-06-30 | Product | Grant | 503,181 | USD | 0001641172-25-023492 |
| Q2 2025Quarterly · 2025-06-30 | Product | License | 250,000 | USD | 0001641172-25-023492 |
| Q2 2025Quarterly · 2025-06-30 | Product | Research And Development | 213,449 | USD | 0001641172-25-023492 |
| Q1 2025Quarterly · 2025-03-31 | Product | Grant | 210,472 | USD | 0001493152-26-022722 |
| Q1 2025Quarterly · 2025-03-31 | Product | Research And Development Expenses | 183,100 | USD | 0001493152-26-022722 |
| Q4 2024Quarterly · 2024-12-31 | Product | License | 465,169 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Research And Development | 352,207 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Product | License | 1,890,169 | USD | 0001493152-26-012672 |
| FY 2024Yearly · 2024-12-31 | Product | Research And Development | 1,605,220 | USD | 0001493152-26-012672 |
| Q3 2024Quarterly · 2024-09-30 | Product | License | 1,425,000 | USD | 0001493152-25-021908 |
| Q3 2024Quarterly · 2024-09-30 | Product | Research And Development | 532,500 | USD | 0001493152-25-021908 |
| Q2 2024Quarterly · 2024-06-30 | Product | License | 0 | USD | 0001437749-24-026392 |
| Q2 2024Quarterly · 2024-06-30 | Product | Research And Development | 385,896 | USD | 0001437749-24-026392 |
| Q1 2024Quarterly · 2024-03-31 | Product | Grant | 0 | USD | 0001437749-25-016866 |
| Q1 2024Quarterly · 2024-03-31 | Product | Research And Development | 334,617 | USD | 0001437749-25-016866 |
| FY 2023Yearly · 2023-12-31 | Product | License | 352,941 | USD | 0001437749-25-009350 |
| FY 2023Yearly · 2023-12-31 | Product | Research And Development | 2,545,865 | USD | 0001437749-25-009350 |
| FY 2022Yearly · 2022-12-31 | Product | License | 247,059 | USD | 0001437749-24-009857 |
| FY 2022Yearly · 2022-12-31 | Product | Research And Development | 2,683,244 | USD | 0001437749-24-009857 |
| FY 2021Yearly · 2021-12-31 | Product | License | 0 | USD | 0001437749-23-008425 |
| FY 2021Yearly · 2021-12-31 | Product | Research And Development | 2,403,831 | USD | 0001437749-23-008425 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.